Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation;Atiopathogenetische Differenzierung der entzundlichen Kardiomyopathie. Immunsuppression und Immunmodulation

Internist

Volumn 38, Issue 6, 1997, Pages 590-601

  Kuhl U ^a   Pauschinger, M ^a   Schultheiss H P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTISONE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERFERON; THYMOCYTE ANTIBODY; IMMUNOLOGICAL ADJUVANT;

AGED; CARDIOMYOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; PATHOGENESIS; REVIEW; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; HEART MUSCLE; IMMUNOLOGY; MYOCARDITIS; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS; MYOCARDIUM;

EID: 0030997383     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050071     Document Type: Review

References (105)

1. Anderson JL, Fowles RE, Unverferth DV, Mason JW (1987) Immunosuppressive therapy of myocardial inflammatory disease - Initial experience ans future trials to define indications for therapy. Eur Heart J 8 [Suppl]:263-266
2. Archard LC, Bowles NE, Cunningham L, Freeke CA, Olsen EG, Rose ML, Meany B, Why HJF, Richardson FJ (1991) Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 12 [Suppl D]:56-59
3. Aretz HT (1987) Myocarditis, the Dallas Criteria. Human Pathol 18:619-624
4. Bachmaier K, Pummerer C, Kozieradzki I, Pfeffer K, Mak TW, Neu N, Penninger JM (1997) Low-molecular-weight Tumor Necrosis Factor Receptor p55 controls induction of autoimmune heart disease. Circulation 95:655-661
5. Badorff C, Kühl U, Schultheiß HP (1997) Cell-mediated cytotoxicity in idiopathic. Correlation dilated cardiomyopathy. Correlation with locally activated T lymphocytes and interstitial fibrosis. JACC (in press)
6. Barnett LA, Fujinami RS (1992) Molecular mimicry: a mechanism autoimmune injury. FASEB J 6:840-844
7. Billingham ME (1987) Acute myocarditis: a diagnostic dilemma. Br Heart J 58:6-8
8. Bowles NE, Richardson PJ, Olson EGJ, Archard LC (1986) Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 17:1120-1123
9. Caforio ALP (1994) Role of autoimmunity in dilated cardiomyopathy. Br Heart J 72:30-34
10. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585
11. Chow LH, Ye Y, Linder J, McManus BM (1989) Phenotypic analysis of Infiltrating cells in human myokarditis. Arch Pathol Lab Med 113:1357-1362
12. Cunningham MW (1993) Bacterial antigen mimicry. In: Bona CA, Siminovitch K, Theophiloupoulos AN et al (eds) The Pathology of autoimmunity. New York, Academic Publishers, pp245-263
13. Cunnion RE, Parillo JE (1995) Immunosuppressive therapy for myocarditis. N Engl J Med 333:1713
14. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389
15. Fujinamy RS, Oldstone MBA, Wroblewska Z, Frankel ME, Koprowski H (1983) Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 80:2346-2350
16. Gauntt C, Higdon A, Bowers D, Maull E, Wood J, Crawley R (1993) What lessons can be learned from animal model studies in viral heart disease? Scand J Infect Dis 88:49-65
17. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R (1995) Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies and myocarditis. J Immunol 154:2983-2995
18. Giesecke J (1987) The long-term prognosis in acute myocarditis. Eur Heart J8 [Suppl J]:251-253
19. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci 86:6753-6757
20. Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, Bramerio M, Gavazzi A, Vigano M, Milanesi G (1992) Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 69:658-664
21. Hahn EA, Hartz VL, Moon TE, O'Connell JB, Herskowitz A, McManus BM, Mason JW, for the Myocarditis Treatment Trial Investigators (1995) The myocarditis treatment trial: design, methods and patient enrollment. Eur Heart J 16 [Suppl 0]:162-167
22. Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimen from 38 patients with lymphocytic myocarditis: Implication for role of sampling error. Mayo Clin Proc 64:1235-1245
23. Helin M, Savola J, Lapinleimu K (1968) Cardiac manifestations during a coxsackie B5 epidemic. Br Med J 3:97-99
24. Henke A, Huber S, Stelzner A, Whitton JL (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720-6728
25. Herskowitz A, Wu T-C, Willoughby SB, Vlahov D, Amsari AA, Beschorner WE, Baughman KL(1994) Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficency virus. J Am Coll Cardiol 24:1025-1032
26. Herzum M, Huber SA, Weller R, Grabe R, Maisch B. (1991) Treatment of experimental murine coxsackie B3 myocarditis. Eur Heart J 12 [Suppl D]:200-201
27. Heusch A, Kühl U, Rammos S, Krogmann ON, Schultheiß HP, Bourgeous M (1996) Complete AV-block in two children with immunohistological proven myocarditis. Eur J Pediatr 155:633-636
28. Huber SA, Lodge PA (1984) Coxsackievirus B3 myocarditis: identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 122:284-291
29. Huber SA, Polgar J, Moraska A, Cunningham M, Schwimmbeck P, Schultheiss HP (1993) T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Diseases 88:67-78
30. Huber SA, Polgar J, Schultheiss P, Schwimmbeck P (1994) Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 68:195-206
31. Huber SA, Mortensen A, Moulton G (1996) Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of Balb/c mice initiated by cells expressing the γδ+T cell receptor. J Virol 70:3039-3044
32. Jin O, Sole MJ, Butany JW, Chia W-K, McLaughlin PR, Liu P, Liew CC (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation82:8-16
33. Kandolf R, Canu A, Hofschneider PH (1985) Coxsackie B3 virus can replicate in cultured human fetal heart cells and is inhibited by interferon. J Interferon Res 5:137-142
34. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart diesease. Proc Natl Acad Sci 84:6272-6276
35. Kandolf R, Klingel K, Mertsching H, Canu A, Hohenadel C, Zell R, Reimann BY, Heim A, McManus BM, Foulis AK, Schultheiss H-P, Erdmann E, Riecker G (1991) Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Europ Heart J 12 [Suppl D]:49-55
36. Kandolf R, Klingel K, Zell R, Selinka HC, Raab U, Schneider-Brachen W, Bultmann B (1993) Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35:140-151
37. Kawai C, Matsumori A, Fujiwara H (1987) Myocarditis and dilated cardiomyopathy. Ann Rev Med 38:221-239
38. Kelly RA Smith TW (1997) Cytokines and cardiac function. Circulation 95:778-781
39. Kishimoto C, Crumpacker CS, Abelmann WH (1988) Prevention of murine coxsackie-B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leukocyte interferon alpha A/D. Cardiovasc Res 22:732-738
40. Kishimoto C, Abelmann WH (1990) In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice. Immature but antigen specific T cells aggravate cardiac injury. Circ Res 67:589-589
41. Koide H, Kitaura Y, Deguchi H, Ukimura A, Kawamura K, Hirai K. (1992) Genomic detection of enteroviruses in the myocardium - studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 56:1081-9327
42. Kühl U, Toussaint M, Ulrich G, Wagner D, Wolff P, Schultheiss HP (1988) Evaluation of immunohistological data for the diagnosis of myocarditis. In: Schultheiss HP (ed) New concepts of viral heart disease. Springer, Berlin Heidelberg New York, pp325-336
43. Kühl U, Melzner B, Schäfer B, Schultheiß H-P, Strauer BE (1991) The Ca-channel as cardiac autoantigen. Eur Heart J 12:99-104
44. Kühl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE (1992) Dilated cardiomyopathy - a chronic myocarditis? Herz 17:97-106
45. Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996a) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295-300
46. Kühl U, Schultheiß HP (1996b) Diagnostisches Vorgehen bei Verdacht auf Myokarditis. Z Sportmed 47:153-161
47. Kühl U, Noutsias M, Seeberg B, Schannwell M, Welp LB, Schultheiss H-P (1994a) Chronic inflammation in the myocardium of patients with clinically suspected dilated cardiomyopathy. J Card Failure 1:13-27
48. Kühl U, Noutsias M, Seeberg B, Schannwell M, Welp LB, Schultheiss H-P (1994b) Immunohistological evaluation of myocardial biopsies from patients with dilated cardiomyopathy. J Heart Failure 9:231-245
49. Kühl U, Schultheiss H-P, Strauer BE (1994c) Methylprednisolone in chronic myocarditis. Postgrad Med J 70 [Suppl 1]:35-42
50. Kühl U, Pauschinger M, Schultheiß HP (1997) Neue Konzepte zur Diagnostik der entzündlichen Herzmuskelerkrankung. DMW 122:690-697
51. Lane JR, Neumann DA, LaFond-Walker A, Herskowitz A, Rose NR (1992) Interleukin I or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10A mice. J Exp Med 175:1123-1129
52. Levine HD (1979) Virus myocarditis: a critique of the literature from clinical, electrocardiographic and pathological stand-points. Am J Med 277:132-143
53. Limas CJ, Goldenberg IF, Limas C (1984) Autoantibodies against adrenoceoptors in human idiopathic dilated cardiomyopathy. Europ Heart J 5:97-103
54. Lutton CW, Gauntt CJ (1985) Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 5:137-146
55. Maisch B (1990) Myocarditis. Curr Opion Cardiol 5:320-327
56. Maisch B, Camerini F, Schultheiss HP (1995a) Immunosuppressive therapy for myocarditis [letter]. N Engl J Med 333:1713
57. Maisch B, Herzum M, Hufnagel G, Bethge C, Schönian U (1995b) Immunosuppressive treatment for myocarditis and dialled cardiomyopathy. Eur Heart J 16 [Suppl O]:153-161 m14
58. Maisch B, Herzum M, Hufnagel G, Schönian U (1996) Immunosuppressive and immunomodulatory treatment for myocarditis. Current Opin Cardiol 11:310-324
59. Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure. Reorganizing the role of proinflammatory cytokines. Chest 105:897-904
60. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearny D, Zhang Y-H, Bodurtha J, Gelb B, Ni J, Bricker JT, Towbin JA (1994) Acute myocarditis, rapid diagnosis py PCR in children. Circulation 90:330-339
61. Mason JW, O'Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269-275
62. Matsumori Acrumpacker CS, Abelmann WH (1987) Protective effect of recombinant alpha interferon on coxsackie B3 myocarditis in mice. Am Heart J 115:1229-1237
63. Matsumori A, Yamada T, Kawai C (1991) Immunomodulating therapy in viral myocarditis: effects of tumor necrosis factor, interleukin 2 and anti-interleukin-2 receptor antibody in an animal model. Eur Heart J 12 [Suppl D]:203-205
64. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72:561-566
65. Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92:2519-2525
66. Matsumori A (1996) Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 11:302-309
67. McKenna WJ, Davies MJ (1995) Immunosuppression for myocarditis (Editorial). N Engl J Med 333:312-313
68. Miric M, Miskovic A, Brkic S, Vasiljevic J, Keserovic N, Pesic M (1995) Interferon and thymic hormones in the therapy of human Myocarditis and idiopathic cardiomyopathy. Eur Heart J 16 [Suppl O]:150-157
69. Neta R, Oppenheim JJ, Durum SK (1990) The cytokine concept: historical perspectives and current status of the cloned cytokines. In: Cohen S (ed) Lymphokines and immune response. Boca Raton, FL: CRC Press Inc, pp29-42
70. O'Connel JB, Reap EA, Robinson JA (1986) The effects of cyclosporin on acute murine Coxsackie B3 myocarditis. Circulation 73:353-359
71. Pauschinger M, Preis S, Triesch A, Doerner A, Schultheiss H-P (1994) Detection of enteroviral RNA in patients having chronic myocarditis respectively dilated cardiomyopathy. Circulation 90:1174
72. Rager-Zisman B, Allison C (1979) Effects of immunosuppression on coxsackie B3 virus infection in mice, and passive protection by circulating antibody. J Gen Virol 19:339-342
73. Rose NR, Neumann DA, Herskowitz A (1992) Coxsackievirus myocarditis. Adv Intern Med 37:411-429
74. Sato S, Tsutsumi R, Burke A, Carson G, Porro V, Seko Y, Okumura K, Kawana R, Virmani S (1994) Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions. J Gen Virol 75:2911-2924
75. Schönian U, Crombach M, Maisch B (1993) Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. Clin Immunol Immunopathol 68:229-233
76. Schultheiss H-P, Schwimmbeck P, Bolte H-D (1983) Autoantibodies against the adenine nucleotide translocator in myocarditis and dilated cardiomyopathy. In: Bolte HD (ed) Viral heart disease. Springer, Berlin New York, pp131-43
77. Schultheiss HP, Schwimmbeck P, Bolte H-D, Klingenberg M (1985) The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol 6:311-327
78. Schultheiss HP (1987) The mitochondrium as antigen in inflammatory heart disease. Eur Heart J 8 [Suppl J]:203-210
79. Schultheiss HP, Janda I, Kühl U, Ulrich G, Morad M (1988) Antibodies against the ADP/ATP carrier interact with the calcium channel and induce cytotoxicity by enhancement of calcium permeability. In: Morad M, Nayler W, Kazda S, Schramm M (eds) The calcium channel: structure, function and implications. Springer, Berlin Heidelberg New York, pp619-631
80. Schultheiss HP (1989) The significance of autoantibodies against ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy - clinical and experimental data. Semin Immunopath 11:15-30
81. Schultheiß HP, Kühl U, Schulze K, Schwimmbeck P, Strauer BE (1990) Biomolecular changes in dilated cardiomyopathy. In:Baroldi G, Camarini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg, pp221-234
82. Schultheiss HP (1992) Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Basic Res Cardiol 87:311-320
83. Schultheiß HP (1992) Immunsuppressive Therapie bei Myokarditis und dilatativer Kardiomyopathie. Internist 33:650-662
84. Schultheiss HP (1993) Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. Circulation 87 [5 Suppl]:IV43-IV48
85. Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE (1995) Antibody-mediated imbalance of myocardial energy metabolism, a causal factor of cardiac failure. Circ Res 76:64-72
86. Schultheiß HP, Schulze K, Dörner A (1996) Significance of the adenine nucleotide translocator in the pathogenesis of viral heart disease. Molec Cell Biochem 163/164:319-327
87. Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dialted cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64:179-9253
88. Schwimmbeck PL, Badorff C, Schultheiss H-P, Strauer BE (1994a) Transfer of human MC into severe combined immunodeficency mice. Circ Res 75:156-164
89. Schwimmbeck PL, Hohmann C, Holtkamp A, Schwimmbeck NK (1994b) Cytokines in the peripheral blood of patients with myocarditis and their correlation with immunohistological findings in endomyocardial biopsies. Circulation 90:1219
90. Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiß HP (1996) The role of sensetized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54:117-125
91. Schwimmbeck PL, Huber SA, Schultheiß HP (1997) Roles of T-cells in CBV-induced disease. Current Topics in Microbiol Innunol (im Druck)
92. Shanes JG, Ghali J, Billingham ME, Ferrans VJ, Fenoglio JJ, Edwards WD, Tsai CC, Saffitz JE, Isner J, Furner S, Subramanian R (1987) Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75:401-405
93. Shioi TS, Matsumori A, Sasayama S (1996) Persistent expression of cytokine in the chronic stage of viral myocarditis. Circulation 94:2930-2937
94. Stille Siegener M, Heim A, Figulla HR (1995) Subclassification of dilated cardiomyopathy and interferon treatment. Eur Heart J 16 [Suppl O]:147-149
95. Tomioka N, Kishimoto C, Matsumori A, Kawai C (1986) Effects of prednisolone on acute viral myocarditis in mice. Am Coll Cardiol 7:868
96. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-α and tumor necrosis factor Receptors in the failing human heart. Circulation 93:704-711
97. Tracy S, Chapmann NM, McManus BM, Pallansch MA, Beck MA, Carstens J (1990) A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22:403-414
98. Tracy S, Wiegand V, McManus B, Gauntt C, Pallansch M, Beck M, Chapman N (1990) Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J Am Coll Cardiol 15:1688-1694
99. Vester EG, Emschermann C, Strobbe U, Ochiulet-Vester J, Perings C, Kühl U, Schultheiß HP, Pölitz B, Heydthausen M, Strauer BE (1994) Late potentials and heart rate variability in heart muscle disease. Eur J Cardiol 15 [Suppl]:25-33
100. Wallukat G, Luther HP, Müller J, Wollenberger A (1996) The possible pathogenetic role of autoantibodies in myocarditis and dilated cardiomyopathy. In:Schultheiß HP, Schwimmbeck P (eds) The role of immnue mechanisms in cardiovascular disease. Springer, Berlin Heidelberg New York, pp77-84
101. Weiss LM, Movahed LA, Billingham ME, Cleary ML (1991) Detection of coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol 138:497-503
102. WHO (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on The Definition and Classificytion of Cardiomyopathies. Circulation 93:841-842
103. Wolff P, Kühl U, Schultheiss HP (1989) Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 117:1303-1309
104. Woodruff JF, Woodruff JJ (1974) Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Immunol 113:1726-1734
105. Yokoyama T, Rossen VL, Durante W, Hazarika P, Mann DL (1993) Cellular basisfor the negative inotropic effects of tumor necrosis factor-alpha in adult mammalian heart. J Clin Invest 92:2302-2312